BRCA1 carries tumor suppressor activity distinct from that of p53 and p21

Cancer Gene Therapy

Volumn 8, Issue 10, 2001, Pages 759-770

  Randrianarison, Voahangy ^a   Marot, Didier ^a   Foray, Nicolas ^a   Cabannes, Jeannine ^a   Méret, Vincent ^a   Connault, Elisabeth ^a   Vitrat, Natacha ^a   Opolon, Paule ^a   Perricaudet, Michel ^a   Feunteun, Jean ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Antitumor activity; BRCA1; p21; p53

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; PROTEIN P21; PROTEIN P53; VIRUS VECTOR;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; GENE TARGETING; GENE TRANSFER; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; TUMOR REGRESSION; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BRCA1 PROTEIN; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; GENE THERAPY; GENES, TUMOR SUPPRESSOR; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, NUDE; OVARIAN NEOPLASMS; SEQUENCE DELETION; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

ADENOVIRIDAE;

EID: 0034774667     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700366     Document Type: Article

References (45)

1. Breast cancer and genetic instability: The molecules behind the scenes
2. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
3. From BRCA1 to RAP1: A widespread BRCT module closely associated with DNA repair
4. BRCA1 protein products: Functional motifs
5. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas
6. Association of BRCA1 with Rad51 in mitotic and meiotic cells
7. Association of BRCA1 with the hRad50-hMrell-p95 complex and the DNA damage response
8. Requirement of ATM dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks
9. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures
10. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
11. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase a
12. BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair
13. Transcription-coupled repair of 8-oxoguanine: Requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome
14. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of theoxidative 8-oxoguanine lesion in human cells
15. wAF1/CiP1
16. BRCA1 physically associates with p53 and stimulates its transcriptional activity
17. BRCA1 regulates p53-dependent gene expression
18. CBP/p300 interact with and function as transcriptional coactivators of BRCA1
19. Chromatin remodeling and activation of chromosomal DNA replication by an acidic transcriptional activation domain from BRCA1
20. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner
21. Construction and characterization of recombinant adenoviruses expressing human BRCA1 or murine Brca1 genes
22. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression
23. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells
24. Induction of apoptosis by the tumor suppressor protein BRCA1
25. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1
26. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression
27. Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts
28. Growth retardation and tumour inhibition by BRCA1
29. BRCA1-associated growth arrest is RB-dependent
30. Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice
31. Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2
32. Cisplatin-induced apoptosis and p53 gene status in a cisplatin-resistant human ovarian carcinoma cell line
33. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier
34. Retrovirus-mediated p53 gene therapy
35. Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins
36. BRCA1 signals ARF-dependent stabilization and coactivation of p53
37. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
38. Ovarian cancer BRCAI gene therapy: Phase I and II trial differences in immune response and vector stability
39. A phase I trial of retroviral BRCA1sv gene therapy in ovarian cancer
40. Growth retardation and tumor inhibition by BRCA1
41. BRCA1 as a potential human prostate tumor suppressor: Modulation of proliferation, damage responses and expression of cell regulatory proteins
42. Increased level of p21 in human ovarian tumors is associated with increased expression of cdk2, cyclin A and PCNA
43. Adenovirus-based p53 gene therapy in ovarian cancer
44. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity
45. The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin